Unternehmen Dishman Carbogen Amcis Limited Bombay S.E.
Aktien
A2DVLD
INE385W01011
DCAL
Pharmazeutika
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
229,4 INR | -1,71 % | +3,71 % | +34,34 % |
01.04. | Dishman Carbogen Amcis Limited gibt das Ausscheiden aus dem Vorstand bekannt | CI |
19.03. | Dishman Carbogen Amcis Arm erhält GMP-Zertifikat von brasilianischer Behörde für Standort Shanghai | MT |
Kurzporträt
Mitarbeiterzahl: 1 295
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Contract Research and Manufacturing Services
80,6
%
| 16 493 | 77,0 % | 19 453 | 80,6 % | +17,95 % |
Marketable Molecules (including Others)
19,4
%
| 4 914 | 23,0 % | 4 676 | 19,4 % | -4,83 % |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
India
100,0
%
| 367 | 1,7 % | 24 129 | 100,0 % | +6.483,68 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 38 | 07.04.12 | |
Harshil R. Dalal
DFI | Director of Finance/CFO | 42 | - |
Paolo Armanino
COO | Chief Operating Officer | - | - |
Compliance Officer | 37 | 17.03.17 | |
Dharmesh Desai
LAW | General Counsel | - | - |
Martin Schneider
PRN | Corporate Officer/Principal | - | - |
Stephan Fritschi
PRN | Corporate Officer/Principal | 63 | - |
Dieter Thueer
HRO | Human Resources Officer | - | - |
Alan Fischer
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 73 | 17.03.07 | |
Director/Board Member | 73 | 17.03.17 | |
Director/Board Member | 76 | 17.03.17 | |
Chief Executive Officer | 38 | 07.04.12 | |
Subir Kumar Das
BRD | Director/Board Member | 70 | 17.03.17 |
Director/Board Member | 42 | 01.04.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 156 783 095 | 46 925 444 ( 29,93 %) | 0 | 29,93 % |
Unternehmenskontakt
Dishman Carbogen Amcis Ltd.
Dishman Corporate House Opp. Jayantilal Park BRTS
380058, Ahmedabad
+91 27 1742 0102
http://imdcal.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Dishman Europe Ltd.
Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The private company is based in London, UK. Dishman Europe was founded in 1997. |
Pharmaceuticals: Major
|
Dishman Netherlands BV
Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The private company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. |
Pharmaceuticals: Other
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Quartalsumsätze - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+25,83 % | 653 Mrd. | |
+27,00 % | 556 Mrd. | |
-6,76 % | 354 Mrd. | |
+20,34 % | 331 Mrd. | |
+3,00 % | 296 Mrd. | |
+13,09 % | 233 Mrd. | |
+5,46 % | 201 Mrd. | |
-9,61 % | 193 Mrd. | |
-6,26 % | 144 Mrd. |
- Börse
- Aktien
- A2DVLD Aktie
- A2DVLD Aktie
- Unternehmen Dishman Carbogen Amcis Limited